Prevalence of KRAS, NRAS, and BRAF gene mutations in metastatic colorectal cancer patients: A systematic literature review and meta-analysis

MLA

Kimberly Lowe, et al. “Prevalence of KRAS, NRAS, and BRAF Gene Mutations in Metastatic Colorectal Cancer Patients: A Systematic Literature Review and Meta-Analysis.” Journal of Clinical Oncology, vol. 37, Feb. 2019, p. 523. EBSCOhost, https://doi.org/10.1200/jco.2019.37.4_suppl.523.

APA

Kimberly Lowe, Lauren C. Bylsma, Jon P. Fryzek, Laura Sangaré, Dominik D. Alexander, & Elizabeth Levin-Sparenberg. (2019). Prevalence of KRAS, NRAS, and BRAF gene mutations in metastatic colorectal cancer patients: A systematic literature review and meta-analysis. Journal of Clinical Oncology, 37, 523. https://doi.org/10.1200/jco.2019.37.4_suppl.523

Chicago

Kimberly Lowe, Lauren C. Bylsma, Jon P. Fryzek, Laura Sangaré, Dominik D. Alexander, and Elizabeth Levin-Sparenberg. 2019. “Prevalence of KRAS, NRAS, and BRAF Gene Mutations in Metastatic Colorectal Cancer Patients: A Systematic Literature Review and Meta-Analysis.” Journal of Clinical Oncology 37 (February): 523. doi:10.1200/jco.2019.37.4_suppl.523.